“…Superfusion of the spinotrapezius muscle with GLI was employed herein to locally inhibit K ATP channels in vivo. This topical drug delivery method was chosen to prevent the potential confound of alterations in central hemodynamics (e.g., MAP, HR, systemic vascular resistance), myocardial hemodynamics and function (e.g., coronary vascular conductance and O 2 delivery, left ventricular relaxation rate), sympathetic nerve activity, visceral organ blood flow, blood insulin and glucose concentration, among others with systemic drug administration as reported previously (Colburn, Holdsworth, et al, 2020;Colburn, Weber, et al, 2020;Duncker et al, 2001;Farouque & Meredith, 2003a;Holdsworth et al, 2015Holdsworth et al, , 2016Rocha et al, 2020;Thomas et al, 1997). Nonetheless, it is not possible to pinpoint the (4) VO 2 = DO 2 m × ΔPO 2 site of GLI action (e.g., across the vascular network and/ or among distinct cell types) with the current experimental protocol.…”